大肠癌患者粪便中癌相关抗原的免疫印迹分析

Analysis of tumor-associated antigen in feces from patients with colorectal cancer by immunoblotting

  • 摘要: 用免疫印迹技术及5株单克隆抗体(CL-3,CL-4,CS-1,GS一2,PS-10)检测大肠癌(39例),肠炎(9例),息肉(12例)患者及正常人的粪便提取液中癌相关抗原(TAA)。结果显示:大肠癌患者粪便中蛋白和TAA区带明显高于正常人、肠炎和息肉患者。TAA的区带数人均值与肠道病变恶性程度呈正相关。TAA片段(分子量>80KD)常在大肠癌中表达,息肉、肠炎患者较少,接近于正常人.,检测阳性率是:大肠癌:CL-373%,C1-470%,CS-141%,GS-263%,PS-10 52%。正常人:4%,10.5%、0%、O%、10.5%。息肉:17%、8%、8%,33%、8%。肠炎:22%、22%、33%、44%、11%。5株单抗检测大肠癌患者粪便TAA中以CL-3,CL-4为好,有临床诊断价值。

     

    Abstract: The tumor-associated antigen (TAA) in feces from patients with colorectal cancer (39 cases), colorectitis (9 cases), enteric polyps (12 cases), and normal controls (36 cases) were assayed by SDS-PAGE and immunoblotting with five monoclonal antibodies (McAbs) (CL-3, CL-4, CS-1, GS-2, and PS-10). The results showed that the number of protein bands in feces from patients with colorectal cancer was significantly higher than that in normal controls. The average number of TAA bands reacted with five McAbs in feces from patients with colorectal cancer was higher than that in enteritis and colorectal polyps. High molecular weight TAA fragments (>80 kD) were usually expressed in cancer, but none or few were found in normal controls, hyperplastic polyps, and enteritis. The positive rates of TAA in feces detected by CL-3, CL-4, CS-1, GS-2, and PS-10 were: colorectal cancer-73%, 70%, 41%, 63%, and 52%; normal controls-4%, 10.5%, 0%, 0%, and 10.5%; polyps-17%, 8%, 8%, 33%, and 8%; enteritis-22%, 22%, 33%, 44%, and 11%, respectively. Therefore, CL-3 and CL-4 McAbs may be useful for the diagnosis of colorectal cancer.

     

/

返回文章
返回